XTL Biopharmaceuticals Ltd. Sponsored ADR Stock
XTL Biopharmaceuticals Ltd. Sponsored ADR Stock price
Key metrics
| Market capitalization | $17.31m |
| Enterprise Value | $15.76m |
| P/E (TTM) P/E ratio | negative |
| EV/Sales (TTM) EV/Sales | 98.50 |
| P/S ratio (TTM) P/S ratio | 108.19 |
| P/B ratio (TTM) P/B ratio | 3.03 |
| Revenue (TTM) Revenue | $160.00k |
| EBIT (operating result TTM) EBIT | $-1.56m |
| Cash position | $1.72m |
Is XTL Biopharmaceuticals Ltd. Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.
XTL Biopharmaceuticals Ltd. Sponsored ADR Stock Analysis
Analyst Opinions
1 Analyst has issued a forecast XTL Biopharmaceuticals Ltd. Sponsored ADR:
Analyst Opinions
1 Analyst has issued a forecast XTL Biopharmaceuticals Ltd. Sponsored ADR:
Financial data from XTL Biopharmaceuticals Ltd. Sponsored ADR
| Sep '24 |
+/-
%
|
||
| Revenue | 0.16 0.16 |
-
|
|
| Gross Profit | 0.05 0.05 |
-
|
|
| EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | -1.56 -1.56 |
97%
97%
|
| Net Profit | -1.06 -1.06 |
53%
53%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about XTL Biopharmaceuticals Ltd. Sponsored ADR directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
XTL Biopharmaceuticals Ltd. focuses on the acquisition and development of proprietary products and late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. The company was founded on March 9, 1993 and is headquartered in Raanana, Israel.
| Head office | Israel |
| CEO | Shlomo Shalev |
| Employees | 8 |
| Founded | 1993 |
| Website | www.xtlbio.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
